News

October 01, 2012

The National Institutes of Health (NIH) has awarded a research grant to Thomas Weimbs for the proposal titled "A Novel Role of Syntaxin 3 as a Transcription Regulator". This is a 2-year Exploratory/Developmental Research Grant Award (R21). The total award for the first year is $219,525.

October 01, 2012

Thomas Weimbs received the 2012 Cottage-UCSB Special Research Award for the proposal titled "An unexpected mechanism underlying genomic stability defects in polycystic kidney disease." This is a $25,000 grant for one year.

September 01, 2012

"Is suppression of cyst growth in PKD enough to preserve renal function?: STAT6 inhibition is a novel promising target", Commentary on our PNAS paper (Olsan et al) in the journal JAK-STAT 

Related Links

August 01, 2012

"Polycystic kidney disease: Modified rapamycin targets PKD", Research Highlight in Nature Reviews Nephrology

Related Links

August 01, 2012

Thomas Weimbs, an Associate Professor in the Molecular, Cellular and Developmental Biology Department since 2007, has a lab at UCSB focuses on uncovering the underlying mechanisms of Autosomal Dominant Polycystic Kidney Disease (ADPKD), a common genetic disease for which a cure still remains elusive. He is a leading expert in biomedical research.

Related Links

August 01, 2012

The relationship between a UCSB researcher and several victims of polycystic kidney disease has led to the development of a new designer drug that can travel through the bloodstream to the kidneys of laboratory animals

Related Links

August 01, 2012

Scientists at UC Santa Barbara have demonstrated in the laboratory that a new drug is effective in treating a very common kidney disease –– although it will be a few years before it becomes available for clinical testing. The findings resulted from a collaboration between UCSB and a biotech firm based in Indiana. The study is published in this week's Journal of the American Society of Nephrology.

Related Links

June 01, 2012

This fellowship will support Jacob's thesis research investigating mechanisms underlying polycystic kidney disease.

Pages